|
26 Companies |
|
24 Products |
|
24 Products |
|
22 Mechanisms of Action |
|
2 Trials |
|
625 News |
|
| «12345678910111213» |
- || Trial completion: An Open, Uncontrolled Study of GK567 in the Deodorization of Malodorous Fungating Neoplastic Tumours (clinicaltrials.gov) - Feb 11, 2013
P3, N=21, Completed, Sponsor: Galderma R&D
Recruiting --> Completed
- Enrollment change: Flexitouch Compression System for Venous Stasis Ulcer (clinicaltrials.gov) - Jan 27, 2013
P4, N=89, Terminated, Sponsor: West Penn Allegheny Health System
Recruiting --> Completed N=126 --> 89
- |||| Trial completion: Clinical Trial to Investigate Treatment With Photodynamic Therapy to Reduce Levels of Bacteria in Leg Ulcers (clinicaltrials.gov) - Jan 22, 2013
P2, N=57, Completed, Sponsor: Photopharmica
N=126 --> 89 Recruiting --> Completed
- Enrollment change: LeucoPatch (clinicaltrials.gov) - Jan 15, 2013
P4, N=62, Completed, Sponsor: Reapplix
Recruiting --> Completed N=50 --> 62
- | New P1/2 trial: The Effect of the Cosmetic Cream NMBM on Leg Ulcers - a Pilot Study (clinicaltrials.gov) - Jan 15, 2013
P1/2, N=30, Not yet recruiting, Sponsor: M.D. Lederman Consulting Ltd
- Trial completion: LeucoPatch (clinicaltrials.gov) - Jan 15, 2013
P4, N=62, Completed, Sponsor: Reapplix
N=50 --> 62 Recruiting --> Completed
- Trial termination: A Pilot Study of the Provant Therapy System in Subjects With Diabetic Foot Ulcers (clinicaltrials.gov) - Jan 13, 2013
P=N/A, N=30, Terminated, Sponsor: Regenesis Biomedical, Inc.
Recruiting --> Completed Recruiting --> Terminated; Protocol Violations noted for 6 of 8 patients
- New P2 trial: [124I]FIAU PET-CT Scanning in Diagnosing Osteomyelitis in Patients With Diabetic Foot Infection (clinicaltrials.gov) - Jan 8, 2013
P2, N=4, Terminated, Sponsor: BioMed Valley Discoveries, Inc
- New P1 trial: Cell Therapy for Venous Leg Ulcers Pilot Study (clinicaltrials.gov) - Dec 13, 2012
P1, N=4, Active, not recruiting, Sponsor: Hospital de Clínicas Dr. Manuel Quintela
- Trial withdrawal: The Mechanism of Action of Unite Biomatrix in Venous Leg Ulcers (clinicaltrials.gov) - Dec 11, 2012
P=N/A, N=0, Withdrawn, Sponsor: Synovis Surgical Innovations
Recruiting --> Terminated; Protocol Violations noted for 6 of 8 patients Terminated --> Withdrawn
- Enrollment change: The Mechanism of Action of Unite Biomatrix in Venous Leg Ulcers (clinicaltrials.gov) - Dec 11, 2012
P=N/A, N=0, Withdrawn, Sponsor: Synovis Surgical Innovations
Terminated --> Withdrawn N=24 --> 0
- midazolam hydrochloride / Generic mfg.
Trial completion: JUVENTAS: Intra-arterial Stem Cell Therapy for Patients With Chronic Limb Ischemia (CLI) (clinicaltrials.gov) - Dec 11, 2012
P1/2, N=160, Completed, Sponsor: UMC Utrecht
N=24 --> 0 Active, not recruiting --> Completed
- Trial withdrawal: STUF: Shockwave Treatment of Diabetic Foot Ulcer: Step I (clinicaltrials.gov) - Dec 9, 2012
P=N/A, N=0, Withdrawn, Sponsor: Technische Universität München
Active, not recruiting --> Completed Not yet recruiting --> Withdrawn
- Enrollment change: STUF: Shockwave Treatment of Diabetic Foot Ulcer: Step I (clinicaltrials.gov) - Dec 9, 2012
P=N/A, N=0, Withdrawn, Sponsor: Technische Universität München
Not yet recruiting --> Withdrawn N=50 --> 0
- ||||| New P4 trial: A Pilot Trial of the Use of ReCell® Autologous Cell Harvesting Device for Venous Leg Ulcers (clinicaltrials.gov) - Dec 4, 2012
P4, N=65, Not yet recruiting, Sponsor: Avita Medical
- ||| Enrollment open: Trial of Dehydrated Human Amnion/Chorion Membrane (dHACM) In the Management of Diabetic Foot Ulcers (clinicaltrials.gov) - Dec 3, 2012
P=N/A, N=120, Recruiting, Sponsor: MiMedx Group, Inc.
N=50 --> 0 Not yet recruiting --> Recruiting
- |||||||||| New P3 trial: Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers >12 cm2 to ≤ 36 cm2 (clinicaltrials.gov) - Nov 28, 2012
P3, N=250, Recruiting, Sponsor: Healthpoint
- |||| Trial completion: A Complicated Skin and Soft-tissue Infection Patient Registry (clinicaltrials.gov) - Nov 28, 2012
P4, N=1081, Completed, Sponsor: Ortho-McNeil Janssen Scientific Affairs, LLC
Not yet recruiting --> Recruiting Recruiting --> Completed
- ||| HEOR: Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix (clinicaltrials.gov) - Nov 18, 2012
P=N/A, N=224, Recruiting, Sponsor: TEI Biosciences Inc.
- Trial completion: OEST: Nutritional Support in Pressure Ulcer Patients (clinicaltrials.gov) - Nov 13, 2012
P=N/A, N=200, Completed, Sponsor: Azienda Ospedaliero Universitaria Maggiore della Carita
Recruiting --> Completed Recruiting --> Completed
- Enrollment change: A Study With Primatrix Dermal Repair Scaffold For The Treatment Of Diabetic Foot Ulcers (clinicaltrials.gov) - Nov 6, 2012
P=N/A, N=30, Completed, Sponsor: TEI Biosciences Inc.
Recruiting --> Completed N=100 --> 30
- | Trial completion: A Study With Primatrix Dermal Repair Scaffold For The Treatment Of Diabetic Foot Ulcers (clinicaltrials.gov) - Nov 6, 2012
P=N/A, N=30, Completed, Sponsor: TEI Biosciences Inc.
N=100 --> 30 Recruiting --> Completed
- | Trial completion: A Multicenter, Prospective, Observational Study With PriMatrix for the Treatment of Neuropathic Diabetic Foot Ulcers (clinicaltrials.gov) - Nov 6, 2012
P=N/A, N=22, Completed, Sponsor: TEI Biosciences Inc.
Recruiting --> Completed Recruiting --> Completed
- Trial completion: Wound Edge Changes Following Treatment With Santyl (clinicaltrials.gov) - Nov 4, 2012
P4, N=10, Completed, Sponsor: Healthpoint
Recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: Enzymatic Versus (vs) Autolytic Debridement of Diabetic Foot Ulcers (clinicaltrials.gov) - Nov 4, 2012
P4, N=20, Completed, Sponsor: Healthpoint
Active, not recruiting --> Completed Active, not recruiting --> Completed
- |||| Trial completion: A Study to Look at the Effects of Four Weeks of Treatment on the Healing of Diabetic Foot Ulcers (clinicaltrials.gov) - Nov 4, 2012
P4, N=57, Completed, Sponsor: Healthpoint
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: Clinical Trial for the Treatment of Diabetic Foot Ulcers Using a Nitric Oxide Releasing Patch: PATHON (clinicaltrials.gov) - Nov 1, 2012
P3, N=100, Completed, Sponsor: Fundación Cardiovascular de Colombia
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | metformin / Generic mfg.
New P2 trial: BA/BE 199/11: BE STUDY OF METFORMIN GSK 1000mg (clinicaltrials.gov) - Oct 17, 2012
P2, N=32, Completed, Sponsor: GlaxoSmithKline
- | metformin / Generic mfg.
New P2 trial: BA/BE 198/11: BE Study of Metformin GSK 850mg (clinicaltrials.gov) - Oct 17, 2012
P2, N=32, Completed, Sponsor: GlaxoSmithKline
- | metformin / Generic mfg.
New P2 trial: BA/BE 173/11: BE Study of Metformin GSK 500mg (clinicaltrials.gov) - Oct 17, 2012
P2, N=32, Completed, Sponsor: GlaxoSmithKline
- Trial completion: VUTEF: Venous Ulcer Treatment With Foam Versus Conservative Treatment (clinicaltrials.gov) - Sep 29, 2012
P=N/A, N=46, Completed, Sponsor: Hospital Occidente de Kennedy
Active, not recruiting --> Completed Recruiting --> Completed
- | Trial completion, Metastases: THERMES ET VEINES: Spa for Prevention of Leg Ulcers (clinicaltrials.gov) - Sep 27, 2012
P3, N=425, Completed, Sponsor: Association Francaise pour la Recherche Thermale
Recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: Pressure Ulcer Multi-disciplinary Teams Via Telemedicine (PUMTT): A Trial in Long Term Care (clinicaltrials.gov) - Sep 26, 2012
P3, N=137, Completed, Sponsor: University of Toronto
Active, not recruiting --> Completed Recruiting --> Completed
- Enrollment open: Evaluation of an E-learning Program for Assessing Pressure Ulcer Risk and Pressure Ulcer Classification - a Pilot Study (clinicaltrials.gov) - Sep 20, 2012
P=N/A, N=90, Recruiting, Sponsor: Oslo University Hospital
Recruiting --> Completed Not yet recruiting --> Recruiting
- ||||||| Trial completion: Study to Evaluate the Performance of AQUACEL® Extra™ in Venous Leg Ulcers (clinicaltrials.gov) - Sep 17, 2012
P3, N=65, Completed, Sponsor: ConvaTec Inc.
Not yet recruiting --> Recruiting Recruiting --> Completed
- Enrollment open: Immune Response of Patients With Chronic, Staphylococcus Aureus-infected Wounds (clinicaltrials.gov) - Sep 16, 2012
P=N/A, N=76, Recruiting, Sponsor: Centre Hospitalier Universitaire de Nīmes
Recruiting --> Completed Not yet recruiting --> Recruiting
- Trial withdrawal: DIPIOS: a Randomized Controlled Trial Comparing Medical and Medical-surgical Treatment in Diabetic Foot Osteomyelitis (clinicaltrials.gov) - Sep 13, 2012
P4, N=0, Withdrawn, Sponsor: Assistance Publique - Hôpitaux de Paris
Not yet recruiting --> Recruiting Recruiting --> Withdrawn
- Enrollment change: DIPIOS: a Randomized Controlled Trial Comparing Medical and Medical-surgical Treatment in Diabetic Foot Osteomyelitis (clinicaltrials.gov) - Sep 13, 2012
P4, N=0, Withdrawn, Sponsor: Assistance Publique - Hôpitaux de Paris
Recruiting --> Withdrawn N=146 --> 0
- Enrollment change: Comparative Study of Amniotic Membrane Wound Graft In the Management of Diabetic Foot Ulcers (clinicaltrials.gov) - Sep 13, 2012
P=N/A, N=25, Completed, Sponsor: MiMedx Group, Inc.
N=146 --> 0 N=40 --> 25
- | Trial completion: Comparative Study of Amniotic Membrane Wound Graft In the Management of Diabetic Foot Ulcers (clinicaltrials.gov) - Sep 13, 2012
P=N/A, N=25, Completed, Sponsor: MiMedx Group, Inc.
N=40 --> 25 Recruiting --> Completed
- Botox (onabotulinumtoxin A) / GSK, AbbVie, Healis Therap
Enrollment open: Efficacy Study of Botulinum Toxin (BOTOX) Injections to Treat Vocal Fold Granulomas (clinicaltrials.gov) - Sep 10, 2012
P2, N=60, Recruiting, Sponsor: Massachusetts Eye and Ear Infirmary
Recruiting --> Completed Not yet recruiting --> Recruiting
- Enrollment change: HP011-101, HP828-101, and Standard Care for Pressure Ulcers (clinicaltrials.gov) - Sep 9, 2012
P2, N=0, Withdrawn, Sponsor: Healthpoint
Not yet recruiting --> Recruiting N=60 --> 0
- | Botox (onabotulinumtoxin A) / GSK, AbbVie, Healis Therap
New P2 trial: Efficacy Study of Botulinum Toxin (BOTOX) Injections to Treat Vocal Fold Granulomas (clinicaltrials.gov) - Aug 30, 2012
P2, N=60, Recruiting, Sponsor: Massachusetts Eye and Ear Infirmary
- Enrollment change: A Clinical Study of the Safety and Efficacy of MEBO® Wound Ointment in Subjects With Diabetic Foot Ulcers (Pilot) (clinicaltrials.gov) - Aug 22, 2012
P2, N=7, Completed, Sponsor: Skingenix, Inc.
N=60 --> 0 N=14 --> 7
- Enrollment change: A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Venous Leg Ulcers (clinicaltrials.gov) - Aug 22, 2012
P2, N=5, Completed, Sponsor: Skingenix, Inc.
N=14 --> 7 N=14 --> 5
- Clinical: Olivamine-containing Products in the Management of Patients With Nonhealing Lower Extremity Ulcers (clinicaltrials.gov) - Aug 2, 2012
P=N/A, N=50, Not yet recruiting, Sponsor: De La Salle University Medical Center
- |||||||||| New P3 trial: Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers (clinicaltrials.gov) - Aug 1, 2012
P3, N=440, Active, not recruiting, Sponsor: Healthpoint
- |||| Trial completion: Comparative Study of 3 Dose Regimens of BioChaperone to Becaplermin Gel for the Treatment of Diabetic Foot Ulcer (clinicaltrials.gov) - Jul 31, 2012
P1/2, N=192, Completed, Sponsor: Virchow Group
N=14 --> 5 Recruiting --> Completed
- Biomarker: Research of Prognostic Factors Associated With Healing of Venous Leg Ulcers (clinicaltrials.gov) - Jul 30, 2012
P=N/A, N=104, Completed, Sponsor: Centre Hospitalier Universitaire, Amiens
- Trial completion: Polydeoxyribonucleotide -Placentex Mastelli(Pdrn) for the Treatment of Diabetic Ulcers (clinicaltrials.gov) - Jul 30, 2012
P4, N=215, Completed, Sponsor: University of Messina
Recruiting --> Completed Recruiting --> Completed